Filing Details
- Accession Number:
- 0001209191-20-053925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 20:31:44
- Reporting Period:
- 2020-10-02
- Accepted Time:
- 2020-10-05 20:31:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789617 | Peter Heerma | C/O Retrophin, Inc. 3721 Valley Centre Drive, Suite 200 San Diego CA 92130 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-10-02 | 2,188 | $18.90 | 44,517 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-05 | 2,188 | $19.35 | 42,329 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- Includes 2,705 shares of the Issuer's common stock acquired by the reporting person on May 31, 2020 pursuant to an employee stock purchase program.
Billionaire Hedge Funds
